Patents Assigned to Ethicon, Inc.
-
Patent number: 12778564Abstract: A combined powder and liquid delivery device includes a housing having a powder chamber and a liquid chamber. The device includes an applicator tip having a powder delivery channel extending between a proximal end and a distal end of the applicator tip that is in fluid communication with the powder chamber, and a liquid delivery channel that extends from the proximal to the distal end of the applicator tip that is in fluid communication with the liquid chamber. The delivery device includes a powder inlet port in fluid communication with the powder chamber, and a liquid inlet port in fluid communication with the liquid chamber. A powder delivery system is in fluid communication with the powder inlet port, the powder chamber, and the powder delivery channel. A liquid delivery system is in fluid communication with the liquid inlet port, the liquid chamber, and the liquid delivery channel.Type: GrantFiled: September 10, 2021Date of Patent: November 3, 2026Assignees: Guangzhou Bioseal Biotech Co., Ltd., Ethicon, Inc.Inventors: Shiwei Xie, Jianxin Guo, Yufu Li, Xuelin Guo, Samantha Weber
-
Patent number: 12773471Abstract: Disclosed is a sealant, and techniques for making and using the sealant. The sealant may include three components that, when combined, produce the sealant: an electrophilic component, a nucleophilic component, and a doping component. The electrophilic component may include a first electrophilic material having a first functionality of a first reactive group. The nucleophilic component may include a first nucleophilic material having a second functionality of a second reactive group. The doping component may include a second electrophilic material having a third functionality of the first reactive group greater than the first functionality and/or a second nucleophilic material having a fourth functionality of the second reactive group greater than the second functionality. The doping component may be present in an amount sufficient to provide a 2-20% molar contribution of the first reactive group and/or the second reactive group in the sealant.Type: GrantFiled: March 6, 2023Date of Patent: October 27, 2026Assignee: Ethicon, Inc.Inventor: Salim A. Ghodbane
-
Patent number: 12773470Abstract: The present invention provides a tissue sealing plug comprising a substrate comprising foamed gelatin impregnated with polyethylene glycol that is liquid at room temperature, wherein the weight ratio of polyethylene glycol to foamed gelatin in the substrate is about 4:1 to about 6.8:1 and the substrate is substantially free of air, along with methods of using the plug for closing tissue punctures in the lung.Type: GrantFiled: October 21, 2022Date of Patent: October 27, 2026Assignee: Ethicon, Inc.Inventors: Salim Ghodbane, Sridevi Dhanaraj, Ashley DeAnglis, Guanghui Zhang
-
Patent number: 12773472Abstract: The present invention is directed to hemostatic and/or tissue adhesive formulations comprising crosslinked polysaccharide particles that have been oxidized to generate aldehyde- and carboxylic functional moieties therein, and wherein said formulations further contain a buffer that maintains a slightly alkaline environment. These formulations can be applied onto tissue in the form of a powder, paste or patch to effect hemostasis or sealing.Type: GrantFiled: July 25, 2023Date of Patent: October 27, 2026Assignee: Ethicon, Inc.Inventors: Thomas Weindl, Benjamin Fitz, Gaojie Hu
-
Publication number: 20260295113Abstract: The invention relates to biodegradable bilayer sealants for tissue closure. The sealants of the invention are composed of two layers with different compliances. The layer in immediate contact with the tissue has high compliance. The second layer located immediately above the first sealant layer has low compliance, i.e. the sealant is much stiffer. The burst pressure of the bilayer sealants is enhanced relative to either a single layer elastic sealant or a single layer stiff sealant. The improved sealant compositions herein provide a water-tight seal, can access hard to reach tears, be applied in a dry or wet environment, are low-swelling, and can repair a range of incision or tear sizes. The bilayer sealants are particularly useful for sutureless dural closure or as adjuncts to sutured dural closure. Also provided herein are methods of preparing and using the biodegradable sealant compositions.Type: ApplicationFiled: June 10, 2026Publication date: October 1, 2026Applicant: Ethicon, Inc.Inventors: Salim A. Ghodbane, Sai Veruva, Mark Neubauer
-
Patent number: 12734268Abstract: The present invention is directed to compressed hemostatic tablets or forms comprising a fibrous non-woven oxidized cellulose (OC or ORC) multilayer material compressed into a form stable tablet, further comprising calcium salt, with the tablets rapidly expandable on contact with blood or blood plasma. The compressed forms may further comprise a multi-arm PEG-SG and are dimensionally, preferably with regard to length and width, stable for at least 48 hours after compression. In some embodiments, the compressed forms will expand upon contact with blood from 1.5 to 5 times of tablet length in 5 seconds; from 2 to 6 times of tablet length in 20 seconds; and from 3 to 6 times of tablet length in 5 minutes. The compressed forms are effective in hemostasis in heparinized blood.Type: GrantFiled: November 8, 2022Date of Patent: September 15, 2026Assignee: Ethicon, Inc.Inventors: Yi-Lan Wang, Tien-Jung Lee
-
Patent number: 12721967Abstract: A dispensing system includes a hollow tube having an outer wall with an air vent formed in the outer wall. A valve including a flexible flap is disposed inside the tube. The flexible flap, normally biased into a retracted position, is moveable between an extended position for sealing the air vent and the retracted position for unsealing the air vent. A syringe connector interconnects a syringe with the proximal end of the hollow tube and defines a fluid flow path. A flowable viscous fluid is disposed within the syringe. When a syringe plunger is depressed, the flowable viscous fluid is expelled from the syringe and forced through the fluid flow path and into the proximal end of the hollow tube. When the flowable viscous fluid engages the flexible flap, the flexible flap is forced to move into a position that seals the air vent.Type: GrantFiled: March 16, 2022Date of Patent: September 1, 2026Assignee: Ethicon, Inc.Inventors: Xuelin Guo, Joseph LoRicco, Gabriella Saade, Matthew Chan
-
Patent number: 12714421Abstract: An elastic suture needle for passing through a smaller cannula used in minimally invasive surgery includes an elongated body having a proximal end, a distal end, a length extending from the proximal end to the distal end, a top surface extending along the length of the elongated body, and a bottom surface extending along the length of the elongated body. The elongated body has dimensions that are calculated using the equation T/LN<(2*?)/(?E), where T is the thickness of the elongated body, LN is the length of the neutral axis of the elongated body, ? is the yield strength of the elongated body, and E is the Young's modulus of the elongated body. The elongated body is made of stainless steels such as martensitic stainless steels, austenitic stainless steels, martensitic-aged (mar-aged) stainless steels, and stainless steels sold under the registered trademark ETHALLOY® Needle Alloy.Type: GrantFiled: January 20, 2023Date of Patent: August 25, 2026Assignee: Ethicon, Inc.Inventors: Frank Richard Cichocki, Jr., Christophe Vailhe, Alexander M. Cannara
-
Patent number: 12673129Abstract: The invention relates to biodegradable bilayer sealants for tissue closure. The sealants of the invention are composed of two layers with different compliances. The layer in immediate contact with the tissue has high compliance. The second layer located immediately above the first sealant layer has low compliance, i.e. the sealant is much stiffer. The burst pressure of the bilayer sealants is enhanced relative to either a single layer elastic sealant or a single layer stiff sealant. The improved sealant compositions herein provide a water-tight seal, can access hard to reach tears, be applied in a dry or wet environment, are low-swelling, and can repair a range of incision or tear sizes. The bilayer sealants are particularly useful for sutureless dural closure or as adjuncts to sutured dural closure. Also provided herein are methods of preparing and using the biodegradable sealant compositions.Type: GrantFiled: August 30, 2022Date of Patent: July 7, 2026Assignee: Ethicon, Inc.Inventors: Salim A. Ghodbane, Sai Veruva, Mark Neubauer
-
Patent number: 12672868Abstract: The present invention is directed to coated medical devices, such as implantable and coatable devices, such as sutures, with expanded antibacterial properties, handling, knot slide and in-situ performance and processes for their manufacture and use.Type: GrantFiled: April 27, 2023Date of Patent: July 7, 2026Assignee: Ethicon, Inc.Inventors: Jackie J. Donners, Howard Scalzo, Jr., John Collier, Vedanta Nayak
-
Publication number: 20260183331Abstract: The invention relates to a rapid setting liquid lung sealant that forms a highly adherent and elastic hydrogel. Provided are lung sealants comprising two high molecular weight (20 kDa) multi-arm PEG compositions wherein the first PEG composition includes an alkaline buffer and the second PEG composition includes a mildly acidic buffer for optimized set up time and extended working time. In some embodiments, the PEGs further comprise a radioprotectant such as tocopherol. In some embodiments, a colorant is added to one or both PEGs of the lung sealant to improve visualization of the lung sealant against human lung tissue.Type: ApplicationFiled: October 28, 2025Publication date: July 2, 2026Applicant: Ethicon, Inc.Inventors: Salim A. Ghodbane, Sridevi Dhanaraj, Brian Aitken
-
Patent number: 12611210Abstract: A method for manufacturing a monofilament barbed suture. The method includes positioning a mandrel device adjacent to a rotary mount on which a razor is mounted, the mandrel device comprising a mandrel mounted to a fixture, a filament in contact with a curved surface of the mandrel; and rotating the razor with the rotary mount so that an edge of the razor impinges upon an exterior surface of the filament to impart a linear cut to the filament to a cut depth within the filament to form a barb. The mandrel has a diameter of 4 millimeters or less.Type: GrantFiled: July 8, 2025Date of Patent: April 28, 2026Assignee: Ethicon, Inc.Inventors: Frank Cichocki, Duru Han, Robert Scogna
-
Patent number: 12599624Abstract: The invention relates to a rapid setting liquid lung sealant that forms a highly adherent and elastic hydrogel. Provided are lung sealants comprising two high molecular weight (20 kDa) multi-arm PEG compositions wherein the first PEG composition includes an alkaline buffer and the second PEG composition includes a mildly acidic buffer for optimized set up time and extended working time. In some embodiments, the PEGs further comprise a radioprotectant such as tocopherol. In some embodiments, a colorant is added to one or both PEGs of the lung sealant to improve visualization of the lung sealant against human lung tissue.Type: GrantFiled: August 30, 2022Date of Patent: April 14, 2026Assignee: Ethicon, Inc.Inventors: Salim A. Ghodbane, Sridevi Dhanaraj, Brian Aitken
-
Patent number: 12594692Abstract: The present invention is directed to methods for processing absorbable, slow-to-crystallize poly(p-dioxanone) ground resin and its fines utilizing a twin-screw extruder apparatus to produce uniform pellets. Advantageously, the ground resin materials resulting from solid-state polymerization do not undergo processing, such as sieving, to remove fines from the feedstock for an extrusion and pelletizing system that has been configured with an inverted temperature profile along the extrusion barrel. The resulting PDS pellets have improved resin uniformity and greater polymer yield for improved operational efficiencies and production of extruded filaments.Type: GrantFiled: July 25, 2023Date of Patent: April 7, 2026Assignees: Ethicon, Inc., Cilag GmbH InternationalInventors: Sasa Andjelic, Jitendra Patel, Marc Wisnudel, Luke Orzechowski
-
Patent number: 12576182Abstract: The present invention is directed to a sealant patch for use on or over sensitive tissue, comprising: a flat, flexible, bioresorbable substrate coated by a moisture-activated adhesive on one side thereof, wherein said adhesive is at least partially inactivated in a first portion of said patch, but remains active in peripheral areas surrounding the first portion. The adherence of the first portion to the tissue is weaker versus adherence in the peripheral areas. The adhesive in the first portion is fully or partially inactivated or pre-reacted prior to application of the sealant patch to the tissue.Type: GrantFiled: August 11, 2023Date of Patent: March 17, 2026Assignee: Ethicon, Inc.Inventors: Sai Veruva, Leo B. Kriksunov
-
Patent number: 12576183Abstract: A method of making a biocompatible composition for sealing tissue includes mixing a first fluid having a first reactive component (e.g., an electrophile) and a second fluid having a second reactive component (e.g., a nucleophile) to form a mixture and expressing the mixture. During expression, a pH modifying fluid (e.g., NaOH) is added to the mixture at a rate that changes. In one embodiment, a higher ratio of the pH modifying fluid is added to the mixture during a first expressing stage and a lower ratio of said pH modifying fluid is added to the mixture during a second expressing stage. During the first expressing stage, a mixing ratio of the pH modifying fluid, the first fluid and the second fluid is 0.7-1.4:1:1. During the second expressing stage, the mixing ratio of the pH modifying fluid, the first fluid and the second fluid is 0.12-0.24:1:1.Type: GrantFiled: December 3, 2021Date of Patent: March 17, 2026Assignee: Ethicon, Inc.Inventors: Sridevi Dhanaraj, Salim Ghodbane, Ashley Deanglis, Michael Cardinale, Nicole Smith, Ashwin Viswanath
-
Patent number: 12577400Abstract: Novel compositions and systems for closure of wounds are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.Type: GrantFiled: July 5, 2023Date of Patent: March 17, 2026Assignee: Ethicon, Inc.Inventor: Duan Li Ou
-
Patent number: 12539374Abstract: A system for dispensing a biocompatible reactive formulation includes a first chamber containing a first fluid having a first reactive component, a second chamber containing a second fluid having a second reactive component, and a third chamber containing a third fluid.Type: GrantFiled: February 16, 2022Date of Patent: February 3, 2026Assignee: Ethicon, Inc.Inventors: Jianxin Guo, Salim Ghodbane, Sridevi Dhanaraj
-
Patent number: 12528913Abstract: Novel compositions and systems for closure of wounds with antimicrobial effectiveness are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.Type: GrantFiled: May 24, 2021Date of Patent: January 20, 2026Assignee: Ethicon, Inc.Inventors: Duan Li Ou, Leo Kriksunov, Julian Quintero
-
Patent number: 12514955Abstract: The present invention is directed to an absorbable hemostatic nonwoven patch that utilizes a biocompatible substrate comprised of melt-blown microfibers as webbed sheets that are layered and bonded/entangled in descending density and ascending porosity; with the substrate having a high flexibility, strength and porosity that is suitable for coating cross-linkable active molecules and ability for laparoscopic use or trocar deployment, ultimately for functional use as a highly effective hemostat in addressing problematic bleeding during both open and minimally invasive surgical procedures.Type: GrantFiled: July 25, 2024Date of Patent: January 6, 2026Assignee: Ethicon, Inc.Inventors: Sai Veruva, Jianguo Zhou, Joseph Vliet, Gerard Llanos, Kenneth Keilman